Primary and secondary gliosarcoma: differences in treatment and outcome

Area of Science:

• Neuro-oncology
• Surgical Oncology
• Cancer Research

Background:

• Limited studies compare outcomes of primary versus secondary gliosarcoma.
• Gliosarcoma, a rare variant of glioblastoma, presents unique challenges in treatment and prognosis.

Purpose of the Study:

• To compare the outcomes and survival rates of patients with primary and secondary gliosarcoma.
• To match gliosarcoma data with glioblastoma (GBM) data for comparative analysis.

Main Methods:

• Retrospective analysis of 10 primary and 10 secondary gliosarcoma cases.
• Comparison with 20 primary and 20 secondary glioblastoma (GBM) cases.
• Evaluation of progression-free survival (PFS) and overall survival (OS) post-surgical resection and adjuvant therapy.

Main Results:

• Primary gliosarcoma showed significantly higher progression-free survival (PFS) and median overall survival (mOS) compared to secondary gliosarcoma.
• 1-year survival rates were 70% for primary gliosarcoma versus 10% for secondary gliosarcoma.
• Outcomes for primary gliosarcoma mirrored those of primary GBM, and secondary gliosarcoma outcomes paralleled secondary GBM.

Conclusions:

• Primary gliosarcoma patients experience superior PFS and mOS compared to secondary gliosarcoma patients.
• Secondary gliosarcoma recurrence carries a poor prognosis with limited therapeutic options.
• Gliosarcoma outcomes are comparable to GBM, regardless of primary or secondary status.